GAD1
Basic information
Region (hg38): 2:170813213-170861151
Previous symbols: [ "GAD" ]
Links
Phenotypes
GenCC
Source:
- early infantile epileptic encephalopathy (Definitive), mode of inheritance: AR
- neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities (Limited), mode of inheritance: AR
- developmental and epileptic encephalopathy 89 (Strong), mode of inheritance: AR
- spastic quadriplegic cerebral palsy (Supportive), mode of inheritance: AR
- developmental and epileptic encephalopathy 89 (Limited), mode of inheritance: AR
- cerebral palsy, spastic quadriplegic, 1 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Cerebral palsy, spastic quadriplegic, 1; Developmental and epileptic encephalopathy 89 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 9084927; 15571623; 32282878 |
ClinVar
This is a list of variants' phenotypes submitted to
- Neurodevelopmental_disorder_with_progressive_spasticity_and_brain_white_matter_abnormalities (173 variants)
- Inborn_genetic_diseases (62 variants)
- not_provided (33 variants)
- Developmental_and_epileptic_encephalopathy_89 (18 variants)
- GAD1-related_disorder (7 variants)
- Pyridoxine-dependent_epilepsy (1 variants)
- not_specified (1 variants)
- Hereditary_spastic_paraplegia (1 variants)
- Infantile_spasms (1 variants)
- Refractory_epilepsy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GAD1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000817.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 62 | 1 | 69 | |
| missense | 1 | 2 | 98 | 8 | 1 | 110 |
| nonsense | 4 | 3 | 1 | 8 | ||
| start loss | 0 | |||||
| frameshift | 1 | 2 | 3 | |||
| splice donor/acceptor (+/-2bp) | 2 | 2 | 1 | 5 | ||
| Total | 8 | 10 | 105 | 70 | 2 |
Highest pathogenic variant AF is 0.000017785635
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| GAD1 | protein_coding | protein_coding | ENST00000358196 | 16 | 47939 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125732 | 0 | 16 | 125748 | 0.0000636 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.32 | 217 | 337 | 0.645 | 0.0000194 | 3932 |
| Missense in Polyphen | 69 | 154.08 | 0.44782 | 1813 | ||
| Synonymous | 0.291 | 122 | 126 | 0.967 | 0.00000782 | 1116 |
| Loss of Function | 3.89 | 9 | 33.1 | 0.272 | 0.00000161 | 390 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000904 | 0.0000904 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000164 | 0.000163 |
| Finnish | 0.0000924 | 0.0000924 |
| European (Non-Finnish) | 0.0000532 | 0.0000527 |
| Middle Eastern | 0.000164 | 0.000163 |
| South Asian | 0.0000980 | 0.0000980 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the production of GABA.;
- Pathway
- Alanine, aspartate and glutamate metabolism - Homo sapiens (human);Type I diabetes mellitus - Homo sapiens (human);GABAergic synapse - Homo sapiens (human);Butanoate metabolism - Homo sapiens (human);beta-Alanine metabolism - Homo sapiens (human);Taurine and hypotaurine metabolism - Homo sapiens (human);Carnosinuria, carnosinemia;Ureidopropionase deficiency;GABA-Transaminase Deficiency;2-Hydroxyglutric Aciduria (D And L Form);Beta-Alanine Metabolism;Hypoacetylaspartia;Aspartate Metabolism;Homocarnosinosis;Hyperinsulinism-Hyperammonemia Syndrome;Succinic semialdehyde dehydrogenase deficiency;Taurine and Hypotaurine Metabolism;4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency;Glutamate Metabolism;Canavan Disease;Alanine and aspartate metabolism;MECP2 and Associated Rett Syndrome;One carbon metabolism and related pathways;Biogenic Amine Synthesis;Alanine Aspartate Asparagine metabolism;Glutamate Glutamine metabolism;Methionine Cysteine metabolism;Neuronal System;glutamate dependent acid resistance;Arginine Proline metabolism;GABA shunt;GABA synthesis;GABA synthesis, release, reuptake and degradation;Neurotransmitter release cycle;Transmission across Chemical Synapses
(Consensus)
Recessive Scores
- pRec
- 0.787
Intolerance Scores
- loftool
- 0.483
- rvis_EVS
- -0.51
- rvis_percentile_EVS
- 21.56
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.980
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- glutamate catabolic process;glutamate decarboxylation to succinate;chemical synaptic transmission;gamma-aminobutyric acid biosynthetic process;protein-pyridoxal-5-phosphate linkage;social behavior;locomotory exploration behavior;response to drug
- Cellular component
- plasma membrane;cell cortex;vesicle membrane;axon terminus;presynaptic active zone;inhibitory synapse;clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane
- Molecular function
- glutamate decarboxylase activity;protein binding;glutamate binding;pyridoxal phosphate binding;protein heterodimerization activity;protein N-terminus binding